mRNA |
NSC23766 |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
WZ4002 |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.4 |
mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
UNC0638 |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
avicin D |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.4 |
mRNA |
BRD-K75293299 |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.4 |
mRNA |
KU-55933 |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |